Lightning Round: Cynosure, EMC, Pfizer and More

Cynosure : It’s best-of-breed but the whole “aesthetic enhancement” complex is down because people can’t afford the procedures right now, Cramer said.

Noah Education : “Let’s not use it,” said Cramer. It doesn’t have any solid financials and Capella and ITT are both better.

NovaGold Resources : Cramer recommends two, and only two gold stocks on Mad Money: Barrick Gold as a conservative play, and Yamana as a growth play.

EMC : “Grossly undervalued.” Cramer thinks it’s due for a year-end rally.

Pfizer : With more drugs coming off patent than any other company, Pfizer is “dead money,” according to Cramer. He would rather own Merck , Wyeth , Celgene or Schering-Plough .

Starbucks : Cramer thinks SBUX is headed south of $20. He called it “inconsistent” and “nothing special.”

Advanced Micro : CEO Hector Ruiz holds a spot in Cramer’s Hall of Shame. AMD should not be bought until Ruiz goes.

Goldman Sachs : CEO Lloyd Blankfein “deserves every penny” he’s going to make, Cramer said, because Goldman is the only bank that didn’t screw up the subprime fiasco.

Jim’s charitable trust owns EMC, Schering-Plough and Goldman Sachs.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer

    Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book